• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones.长期亲水性胆汁酸疗法对胆固醇结石患者胆囊肌条体外收缩的影响。
World J Gastroenterol. 2007 Aug 28;13(32):4336-9. doi: 10.3748/wjg.v13.i32.4336.
2
Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones.熊去氧胆酸治疗对胆固醇结石患者体外胆囊收缩功能的影响。
Dig Dis Sci. 1999 Jan;44(1):190-6. doi: 10.1023/a:1026635124115.
3
Direct contractile response of isolated gallbladder smooth muscle cells to cholecystokinin in patients with gallstones.胆结石患者离体胆囊平滑肌细胞对胆囊收缩素的直接收缩反应。
J Surg Res. 1994 May;56(5):434-8. doi: 10.1006/jsre.1994.1068.
4
Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.亲水性而非疏水性胆汁酸可预防急性胆囊炎时胆囊肌肉功能障碍。
Hepatology. 2003 Jun;37(6):1442-50. doi: 10.1053/jhep.2003.50243.
5
Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones.熊去氧胆酸可降低胆固醇结石患者胆囊胆汁的黏稠度和可沉淀部分。
Eur J Gastroenterol Hepatol. 2004 Mar;16(3):305-11. doi: 10.1097/00042737-200403000-00010.
6
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones.熊去氧胆酸可改善有胆固醇结石的症状性胆囊的肌肉收缩力和炎症。
Gut. 2007 Jun;56(6):815-20. doi: 10.1136/gut.2006.109934. Epub 2006 Dec 21.
7
Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.熊去氧胆酸可降低胆固醇结石患者胆囊胆汁中的脂质过氧化作用及粘蛋白促分泌活性。
Eur J Clin Invest. 2008 Sep;38(9):634-9. doi: 10.1111/j.1365-2362.2008.01995.x.
8
Ursodeoxycholic acid protects interstitial Cajal-like cells in the gallbladder from undergoing apoptosis by inhibiting TNF-α expression.熊去氧胆酸通过抑制 TNF-α 的表达来保护胆囊中的间质 Cajal 样细胞免于凋亡。
Acta Pharmacol Sin. 2018 Sep;39(9):1493-1500. doi: 10.1038/aps.2017.206. Epub 2018 May 17.
9
Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial.短期熊去氧胆酸治疗可改善胆结石患者的胆囊胆汁周转率:一项随机试验。
Neurogastroenterol Motil. 2005 Oct;17(5):680-6. doi: 10.1111/j.1365-2982.2005.00683.x.
10
In vitro gallbladder motility in patients with radiolucent and radiopaque stones.透光性结石和不透光性结石患者的体外胆囊运动情况
Digestion. 1991;50(1):22-7. doi: 10.1159/000200736.

引用本文的文献

1
Pien Tze Huang (PZH) as a Multifunction Medicinal Agent in Traditional Chinese Medicine (TCM): a review on cellular, molecular and physiological mechanisms.片仔癀作为传统中药中的多功能药物:关于细胞、分子和生理机制的综述
Cancer Cell Int. 2021 Mar 3;21(1):146. doi: 10.1186/s12935-021-01785-3.
2
Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart.胆汁酸信号概述及熊去氧胆酸(最亲水的胆汁酸)在心脏中信号的展望。
Biomolecules. 2018 Nov 27;8(4):159. doi: 10.3390/biom8040159.
3
Concept of the pathogenesis and treatment of cholelithiasis.胆结石的发病机制与治疗概念。
World J Hepatol. 2012 Feb 27;4(2):18-34. doi: 10.4254/wjh.v4.i2.18.
4
ATP induces guinea pig gallbladder smooth muscle excitability via the P2Y4 receptor and COX-1 activity.三磷酸腺苷通过P2Y4受体和环氧化酶-1活性诱导豚鼠胆囊平滑肌兴奋性。
Am J Physiol Gastrointest Liver Physiol. 2008 Jun;294(6):G1362-8. doi: 10.1152/ajpgi.00043.2008. Epub 2008 Apr 24.

本文引用的文献

1
Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.亲水性而非疏水性胆汁酸可预防急性胆囊炎时胆囊肌肉功能障碍。
Hepatology. 2003 Jun;37(6):1442-50. doi: 10.1053/jhep.2003.50243.
2
Ursodeoxycholic acid therapy in hepatobiliary disease.熊去氧胆酸在肝胆疾病中的治疗作用
Am J Med. 2000 Apr 15;108(6):481-6. doi: 10.1016/s0002-9343(00)00318-1.
3
Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones.熊去氧胆酸治疗对胆固醇结石患者体外胆囊收缩功能的影响。
Dig Dis Sci. 1999 Jan;44(1):190-6. doi: 10.1023/a:1026635124115.
4
Gallbladder relaxation in patients with pigment and cholesterol stones.色素结石和胆固醇结石患者的胆囊松弛情况。
Gastroenterology. 1997 Sep;113(3):930-7. doi: 10.1016/s0016-5085(97)70189-6.
5
Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying.胆结石及熊去氧胆酸疗法对胆囊排空的影响。
Gastroenterology. 1984 Aug;87(2):299-307.
6
[Study of gallbladder emptying using 99m Tc-HIDA in acalculous cholecystopathy].
Schweiz Med Wochenschr. 1987 Aug 15;117(33):1217-20.
7
Motor function of the gallbladder and cholesterol saturation of duodenal bile.胆囊的运动功能与十二指肠胆汁的胆固醇饱和度
Neth J Med. 1987 Apr;30(3-4):160-71.
8
Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones.胆结石溶解过程中的胆囊功能。胆汁酸疗法对胆结石患者的影响。
Gastroenterology. 1988 Sep;95(3):740-8.
9
Gallbladder contraction in patients with pigment and cholesterol stones.
Gastroenterology. 1989 Dec;97(6):1479-84. doi: 10.1016/0016-5085(89)90392-2.
10
Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution.胆固醇结石病中的胆囊运动功能。熊去氧胆酸给药及胆结石溶解的影响。
Gastroenterology. 1990 Dec;99(6):1779-85. doi: 10.1016/0016-5085(90)90487-l.

长期亲水性胆汁酸疗法对胆固醇结石患者胆囊肌条体外收缩的影响。

Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones.

作者信息

Mas Mehmet-Refik, Comert Bilgin, Mas Nuket, Yamanel Levent, Ozotuk Haluk, Tasci Ilker, Jazrawi Riadh-P

机构信息

Department of Internal Medicine, Gülhane School of Medicine, GATA Ic Hasta-liklari B.D., Etlik 06018 Ankara, Turkey.

出版信息

World J Gastroenterol. 2007 Aug 28;13(32):4336-9. doi: 10.3748/wjg.v13.i32.4336.

DOI:10.3748/wjg.v13.i32.4336
PMID:17708607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4250860/
Abstract

AIM

To evaluate ursodeoxycholic acid (UDCA) therapy on the in vitro contraction of gallbladder smooth muscle strips from cholesterol gallstone patients.

METHODS

The contraction forces of gallbladder smooth muscle strips from 28 patients with cholesterol gallstones treated with UDCA were compared with contraction forces from 14 untreated patients. The strips were stimulated with increasing concentrations of cholecystokinin-8 (CCK-8).

RESULTS

Although the contraction forces that developed in response to CCK-8 were higher in strips from specimens of UDCA treated patients compared to untreated patients, longer treatment periods (6-wk) caused more contraction responses than the short treatment period of 3-wk (F = 19.297, 1.85 +/- 0.22 g vs 1.70 +/- 0.10 g, P < 0.01). Contraction forces developed with maximal stimulation with KCl in the 6-wk treatment group were also higher than contraction forces in the untreated group (F = 4.274, 3.77 +/- 0.45 g vs 3.30 +/- 0.30 g, P < 0.05).

CONCLUSION

Six-week UDCA treatment caused an increase in contractions of muscle strips from patients with cholesterol gallstones when compared to shorter treatment administration or controls. We suggest that extending UDCA treatment periods may cause more effective contractions in the gallbladder, and thereby increase the rate of response to treatment.

摘要

目的

评估熊去氧胆酸(UDCA)治疗对胆固醇结石患者胆囊平滑肌条体外收缩的影响。

方法

将28例接受UDCA治疗的胆固醇结石患者的胆囊平滑肌条收缩力与14例未治疗患者的收缩力进行比较。用递增浓度的胆囊收缩素-8(CCK-8)刺激这些肌条。

结果

尽管与未治疗患者相比,接受UDCA治疗患者标本的肌条对CCK-8产生的收缩力更高,但较长的治疗期(6周)比较短的3周治疗期引起更多的收缩反应(F = 19.297,1.85±0.22克对1.70±0.10克,P < 0.01)。6周治疗组用氯化钾最大刺激产生的收缩力也高于未治疗组(F = 4.274,3.77±0.45克对3.30±0.30克,P < 0.05)。

结论

与较短治疗期或对照组相比,六周的UDCA治疗使胆固醇结石患者的肌条收缩增加。我们认为延长UDCA治疗期可能会使胆囊产生更有效的收缩,从而提高治疗反应率。